Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 06/12/2011
PIL Eucreas 50 mg/850 mg and 50 mg/1000 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 21/11/2011 and displayed until 06/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 28/02/2011 and displayed until 21/11/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 16/07/2010 and displayed until 28/02/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to MA holder contact details
Updated on 23/04/2010 and displayed until 16/07/2010
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 24/09/2009 and displayed until 23/04/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to Marketing Authorisation Holder
Updated on 05/12/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/04/2008 and displayed until 05/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 20/03/2008 and displayed until 23/04/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  metformin hydrochloride
  vildagliptin